Oseltamivir Phosphate
NDC 47781-469, Oseltamivir phosphate, capsule, from Alvogen Inc..
- Product NDC
- 47781-469
- Status
- Listed
- Labeler
- Alvogen Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202595
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/47781-469 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OSELTAMIVIR PHOSPHATE45 mg/1
Pharmacologic classes
Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 47781-469-13 | 47781046913 | 1 BLISTER PACK in 1 CARTON (47781-469-13) / 10 CAPSULE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/809f859e-0852-80d3-1a67-da87ed399c15NADAC price for package 47781046913
GET /v1/drugs/nadac/47781046913
Use it
Look up 47781-469 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/47781-469 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 47781-469. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.